BioAtla BCAB
OTC BCAB
$1.65 +0.35 (+26.92%)
At close: Oct 2, 2026 · 4:00 PM EDT

BioAtla (BCAB) Interest & Investment Income (2020 - 2026)

Updated

BioAtla (BCAB) recorded Interest & Investment Income of $16,000 in Q2 2026, down 93.1% from $233,000 a year earlier and down 56.8% from the prior quarter.

Analysis

BioAtla (BCAB) Interest & Investment Income (2020 - 2026) Analysis & Trends

On a TTM basis, BioAtla's Interest & Investment Income came in at $259,000 as of Jun 30, 2026, down 86.2% year-over-year; for FY2025, it came in at $843,000, down 75.0% from FY2024.

  • Annual Interest & Investment Income has a five-year compound annual growth rate of 53.2% (FY2020 to FY2025).
  • Across earlier years, Interest & Investment Income came in at $3.37 million in FY2024 (-46.6%), $6.31 million in FY2023 (+283.0%), $1.65 million in FY2022 (+370.9%) and $350,000 in FY2021 (+250.0%).
  • The Q2 2026 figure is the lowest quarterly Interest & Investment Income since Q2 2020.
  • On a year-over-year basis, Interest & Investment Income has declined for ten consecutive quarters, with an average decline of 77.4% over the last eight quarters.
  • Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 990.6% in Q4 2022, against a decline of 93.1% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $37,000 (Q1 2026), $73,000 (Q4 2025) and $133,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 BioAtla 2.74 Mn 2.74 Mn - 16,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16,000.00
Mar 31, 2026 37,000.00
Dec 31, 2025 73,000.00
Sep 30, 2025 133,000.00
Jun 30, 2025 233,000.00
Mar 31, 2025 400,000.00
Dec 31, 2024 554,000.00
Sep 30, 2024 692,000.00
Jun 30, 2024 900,000.00
Mar 31, 2024 1.22 Mn
Dec 31, 2023 1.64 Mn
Sep 30, 2023 1.73 Mn
Jun 30, 2023 1.46 Mn
Mar 31, 2023 1.48 Mn
Dec 31, 2022 1.05 Mn
Sep 30, 2022 370,000.00
Jun 30, 2022 146,000.00
Mar 31, 2022 85,000.00
Dec 31, 2021 96,000.00
Sep 30, 2021 76,000.00
API Access

BioAtla Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=BCAB&period=max&api_key=YOUR_API_KEY